https://www.selleckchem.com/pr....oducts/pf-06826647.h
In select patients, low dose abiraterone with food may be used to optimize clinical outcomes. Androgen receptor gene splice variant status may be a useful guide to therapy. In addition, generic versions of approved therapies may improve access to treatment to a broader patient population. The choice of treatment, as well as sequencing are guided by both patient and disease characteristics, preferences, drug access, cost, and compliance. Expert recommendations are key to guidance for the optimal management of mPC. Appropriate choice,
Like
Comment
Share
